THANK YOU FOR
SIGNING UP!

Inflammation and fibrosis are a largely unaddressed driver of CKD progression and related CV events1-5
Read more
See how UACR acts as an early marker for CV risk and CKD progression6
Discover more

CKD=chronic kidney disease; CV=cardiovascular; UACR=urine albumin-to-creatinine ratio.

References:

  • Toth-Manikowski S, et al. J Diabetes Res. 2015;2015. doi:10:11552015/697010. Return to content
  • Alicic RZ, et al. Clin J Am Soc Nephrol. 2017;12(12):2032-2045. Return to content
  • Alicic RZ, et al. Adv Chronic Kidney Dis. 2018;25(2):181-191. Return to content
  • Black LM, et al. J Histochem Cytochem. 2019;67(9):663-681. Return to content
  • Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. Kidney Int. 2020;98(4S):S1-S115. Return to content
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Int Suppl. 2013;3(1):1-150. Return to content

Follow:

© 2022 Bayer AG

Last updated in June 2022

This website is intended to provide information to an international audience of healthcare professionals outside the USA and UK.

  • PP-KER-ALL-0077-1
Alt tag Alt tag